JEAN JACQUES BIENAIME

CIK 1221590 · Chief Executive Officer · last filed 2026-06-12

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$29.59M

Companies

6

Total Filings

441

Lifetime Open-Market Net

-$240.35M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
IMNM Director 38,915 $18.22 $709.0K $437.4K 12 2026-06-12
INCY Director 24,424 $101.66 $2.48M $320.5K 45 2026-06-10
KROS Director 16,592 $10.06 $167.0K $44.7K 6 2026-06-05
ASND Director 600 $222.79 $133.7K $206.7K 2 2026-06-01
BMRN Director 473,892 $55.08 $26.10M -$241.37M 336 2024-05-21
PORTOLA PHARMACEUTICALS INC (PTLA) Delisted Director 1,706 $3.9K 4 2014-03-10

Recent Filings · Page 35 of 45

441 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2012-05-03 BMRN Mixed +1,098 -$740.1K EDGAR
2012-04-30 BMRN Mixed −2,000 -$572.7K EDGAR
2012-04-13 Grant (A) +4,225 $0
2012-03-13 BMRN Mixed -$419.8K EDGAR
2012-03-09 BMRN Sell (S) −1,000 -$35.0K EDGAR
2012-03-01 BMRN Sell (S) −1,000 -$36.3K EDGAR
2012-02-28 BMRN Sell (S) −5,000 -$178.2K EDGAR
2012-02-24 BMRN Sell (S) +5,000 $176.5K EDGAR
2012-02-09 Grant (A) $0
2011-09-30 BMRN Sell (S) −1,000 -$32.0K EDGAR
Showing 341350 of 441
Page 35 of 45
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.